Citations
325 citation(s) found for "Wang, Yucai".
Comparison of Treatment-Emergent Adverse Events of Covalent BTK Inhibitors in Clinical Trials in B-Cell Malignancies: A Systematic Review and Meta-Analysis
Wang, Jacqueline F, Jiang, Yi , Qi, Xinyue , Hampel, Paul J. , Leis, José F., Thanarajasingam, Gita , Inwards, David J. , Nowakowski, Grzegorz S. , Ansell, Stephen M. , Wang, Jacqueline , Wang, Jacqueline F , Hwang, Steven R. , Zhang, Shijia , Parikh, Sameer A. , Ding, Wei , Kenderian, Saad S. , Muchtar, Eli , Muñoz, Javier , Paludo, Jonas , Habermann, Thomas M. , Witzig, Thomas E. , Kay, Neil E. , Zhou, Shouhao , Wang, Yucai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9882-9884
Prognosis Score for Overall Survival with CAR-T Therapy in Aggressive Lymphoma
Bansal, Radhika , Khurana, Arushi , Jankowski, Matthew, Hathcock, Matthew , Hampel, Paul J. , Ansell, Stephen M. , Johnston, Patrick B. , Lin, Yi , Bennani, N. Nora , Paludo, Jonas , Wang, Yucai , Durani, Urshila
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9504-9505
Incidence of Second Primary Malignancies in Lymphoma Survivors: A Prospective Cohort Study in the Modern Treatment Era
Mwangi, Raphael , Nowakowski, Grzegorz S. , Thompson, Carrie A. , Desai, Sanjal H. , Wang, Yucai , Farooq, Umar , Mou, Eric , Feldman, Andrew L. , Syrbu, Sergei , Slager, Susan L. , Maurer, Matthew J. , Kay, Neil E. , Habermann, Thomas M. , Link, Brian K. , Cerhan, James R.
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1934-1936
Outcomes with Immunochemotherapy Plus Radiation Versus Immunochemotherapy Alone in Stage I Diffuse Large B-Cell Lymphoma: A Retrospective Study
Ng, Wern Lynn , Bock, Allison M. , Wert, Yijin, Ng, Lay She , Nowakowski, Grzegorz S. , Kovalenko, Iuliia , Wang, Yucai
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3829-3830
Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
He, Rong , Hampel, Paul J. , Call, Timothy G. , Koehler, Amber B. , Behnken, Amy, Leis, José F., Viswanatha, David S., Dyke, Daniel L. Van , Hwang, Steven R. , Wang, Yucai , Rabe, Kari G. , Kenderian, Saad S. , Muchtar, Eli , Kay, Neil E. , Braggio, Esteban , Shi, Min , Slager, Susan L. , Parikh, Sameer A. , Ding, Wei
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12390-12392
Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting
Bock, Allison M. , Tawfiq, Reema, Poonsombudlert, Kittika , Maliske, Seth , Kabat, Brian, Gysbers, Brianna, Smith, Katherine E. , Inwards, David J. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Smith, Katherine E R , Gile, Jennifer , Larson, Melissa C. , Maurer, Matthew J. , Cerhan, James R. , Hwang, Steven R. , Paludo, Jonas , Habermann, Thomas M. , Ayyappan, Sabarish Ram , Witzig, Thomas E. , Farooq, Umar , Wang, Yucai
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6517-6519
Molecular Landscape of Primary Refractory DLBCL
Bock, Allison M. , Wenzl, Kerstin , Stokes, Matthew E. , Hopper, Melissa A. , Dropik, Abigail R. , Sarangi, Vivekananda , Huang, C. Chris , King, Rebecca L. , Ansell, Stephen M. , Gandhi, Anita K. , Nowakowski, Grzegorz S. , Novak, Anne J. , Novak, Joseph P. , Krull, Jordan E. , Ortiz, Maria, Stong, Nicholas , Maurer, Matthew J. , Godby, Richard , Farooq, Umar , Wang, Yucai , Habermann, Thomas M. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9221-9223
Outcomes and Prognostic Factors of Transformed Follicular Lymphoma: An Analysis from the LEO Consortium
Day, Jonathan R , Lossos, Izidore S. , Friedberg, Jonathan W. , Flowers, Christopher R. , Larson, Melissa C. , Casulo, Carla , Wang, Yucai , Chihara, Dai , Kahl, Brad S. , Martin, Peter, Orellana‐Noia, Victor M. , Burack, Richard , Habermann, Thomas M. , Cerhan, James R. , Maurer, Matthew J. , Link, Brian K.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6642-6644
Efficacy of Pirtobrutinib in Covalent BTK-Inhibitor Pre-Treated Relapsed / Refractory Mantle Cell Lymphoma: Additional Patients and Extended Follow-up from the Phase 1/2 BRUIN Study
Wang, Michael , Shah, Nirav N. , Eyre, Toby A. , Ujjani, Chaitra S. , Gerson, James N. , Alencar, Alvaro J. , Patel, Krish , Woyach, Jennifer A. , Lamanna, Nicole , Seymour, John F. , Munir, Talha, Nagai, Hirokazu, Hernandez‐Ilizaliturri, Francisco J. , Kumar, Anita J. , Nair, Binoj C., Tsai, Donald E. , Balbas, Minna, Walgren, Richard A., Abada, Paolo, Wang, Chunxiao , Zhao, Junjie , Mato, Anthony R. , Patel, Krish , Jurczak, Wojciech , Zinzani, Pier Luigi , Cheah, Chan Y. , Koh, Youngil , Izutsu, Koji , Flinn, Ian W. , Tessoulin, Benoit , Ma, Shuo , Lech‐Marańda, Ewa , Rhodes, Joanna , Wang, Yucai , Tam, Constantine S. , Zelenetz, Andrew D. , Jain, Preetesh
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9368-9372
Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma
Tawfiq, Reema, Bock, Allison M. , Poonsombudlert, Kittika , Maliske, Seth , Kabat, Brian, Inwards, David J. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Larson, Melissa C. , Gile, Jennifer , Maurer, Matthew J. , Cerhan, James R. , Smith, Katherine E. , Godby, Richard , Paludo, Jonas , Ayyappan, Sabarish Ram , Habermann, Thomas M. , Witzig, Thomas E. , Farooq, Umar , Wang, Yucai
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6489-6491